Schonfeld Strategic Advisors’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.06M | Buy |
42,950
+31,477
| +274% | +$2.98M | 0.03% | 570 |
|
|
2025
Q1 | $728K | Sell |
11,473
-67,927
| -86% | -$4.31M | ﹤0.01% | 1305 |
|
|
2024
Q4 | $3.69M | Buy |
79,400
+58,978
| +289% | +$2.74M | 0.02% | 566 |
|
|
2024
Q3 | $588K | Sell |
20,422
-201,574
| -91% | -$5.8M | ﹤0.01% | 1229 |
|
|
2024
Q2 | $3.21M | Sell |
221,996
-38,204
| -15% | -$552K | 0.02% | 606 |
|
|
2024
Q1 | $4.19M | Sell |
260,200
-41,800
| -14% | -$673K | 0.03% | 595 |
|
|
2023
Q4 | $6M | Buy |
302,000
+111,594
| +59% | +$2.22M | 0.04% | 433 |
|
|
2023
Q3 | $3.1M | Sell |
190,406
-2,511
| -1% | -$40.9K | 0.02% | 589 |
|
|
2023
Q2 | $4.08M | Sell |
192,917
-142,783
| -43% | -$3.02M | 0.04% | 544 |
|
|
2023
Q1 | $6.74M | Sell |
335,700
-84,097
| -20% | -$1.69M | 0.06% | 367 |
|
|
2022
Q4 | $11M | Buy |
419,797
+360,797
| +612% | +$9.43M | 0.09% | 286 |
|
|
2022
Q3 | $603K | Buy |
59,000
+4,700
| +9% | +$48K | 0.01% | 1591 |
|
|
2022
Q2 | $227K | Sell |
54,300
-4,100
| -7% | -$17.1K | ﹤0.01% | 1743 |
|
|
2022
Q1 | $292K | Buy |
58,400
+400
| +0.7% | +$2K | ﹤0.01% | 1644 |
|
|
2021
Q4 | $390K | Sell |
58,000
-600
| -1% | -$4.03K | ﹤0.01% | 1328 |
|
|
2021
Q3 | $321K | Buy |
58,600
+400
| +0.7% | +$2.19K | ﹤0.01% | 1411 |
|
|
2021
Q2 | $381K | Buy |
58,200
+1,700
| +3% | +$11.1K | ﹤0.01% | 1290 |
|
|
2021
Q1 | $472K | Buy |
56,500
+8,700
| +18% | +$72.7K | 0.01% | 1131 |
|
|
2020
Q4 | $334K | Sell |
47,800
-6,800
| -12% | -$47.5K | ﹤0.01% | 1134 |
|
|
2020
Q3 | $340K | Buy |
+54,600
| New | +$340K | 0.01% | 1013 |
|